A Safety and Efficacy Study of Intranasal GSK2245035 in Adults With Allergic Asthma
Condition:   Asthma Interventions:   Drug: GSK2245035;   Drug: Placebo;   Drug: FP-DPI;   Drug: Albuterol/Salbutamol;   Other: eDairy;   Other: ACQ-6 Sponsor:   GlaxoSmithKline Withdrawn (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2018 Category: Research Source Type: clinical trials